Zhan-Wei Suo Selected Research

2-Amino-5-phosphonovalerate (2 Amino 5 phosphonovalerate)

11/2013	Ca2+ /calmodulin-dependent protein kinase II in spinal dorsal horn contributes to the pain hypersensitivity induced by γ-aminobutyric acid type a receptor inhibition.
5/2011	GABAergic disinhibition induced pain hypersensitivity by upregulating NMDA receptor functions in spinal dorsal horn.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhan-Wei Suo Research Topics

Disease

26	Pain (Aches) 09/2021 - 01/2011
11	Hypersensitivity (Allergy) 09/2021 - 05/2011
9	Inflammation (Inflammations) 05/2021 - 05/2011
9	Hyperalgesia 01/2020 - 05/2011
1	Lymphoma (Lymphomas) 09/2021
1	Neuralgia (Stump Neuralgia) 05/2018
1	Intestinal Diseases (Diseases, Intestinal) 09/2007

Drug/Important Bio-Agent (IBA)

10	Freund's AdjuvantIBA 10/2020 - 07/2013
10	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2019 - 01/2011
5	Formaldehyde (Formol)FDA Link 05/2021 - 01/2018
5	Tyrosine (L-Tyrosine)FDA Link 07/2019 - 11/2011
4	Peptides (Polypeptides)IBA 01/2020 - 02/2015
4	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2018
3	UbiquitinIBA 09/2021 - 01/2019
3	Analgesics (Analgesic Drugs)IBA 07/2019 - 10/2015
3	Protein Tyrosine PhosphatasesIBA 01/2018 - 07/2013
3	BicucullineIBA 03/2015 - 05/2011
3	N-Methylaspartate (NMDA)IBA 03/2015 - 11/2011
2	Glycine Receptors (Glycine Receptor)IBA 05/2021 - 10/2020
2	Adenosine A1 ReceptorIBA 10/2020 - 11/2017
2	neurabinIBA 11/2019 - 10/2015
2	NR2B NMDA receptorIBA 03/2015 - 02/2014
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 02/2014 - 11/2013
2	2-Amino-5-phosphonovalerate (2 Amino 5 phosphonovalerate)IBA 11/2013 - 05/2011
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2021
1	Ligases (Synthetase)IBA 09/2021
1	StrychnineIBA 05/2021
1	Protein Kinase CIBA 05/2021
1	Vesicle-Associated Membrane Protein 2 (VAMP2)IBA 01/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020
1	SNARE Proteins (SNAREs)IBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 07/2019
1	CarrageenanIBA 07/2019
1	Metabotropic Glutamate 5 ReceptorIBA 01/2019
1	gaboxadol (THIP)IBA 10/2018
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 05/2018
1	Proteins (Proteins, Gene)FDA Link 05/2018
1	Streptozocin (Streptozotocin)FDA Link 05/2018
1	neuroligin 1IBA 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 11/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	PaxillinIBA 03/2016
1	Protein Phosphatase 1IBA 10/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2015
1	Focal Adhesion Protein-Tyrosine KinasesIBA 06/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 03/2015
1	Glutamate Receptors (Glutamate Receptor)IBA 03/2015
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 02/2014
1	Clonidine (ST 155)FDA LinkGeneric 02/2014
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2014
1	KN 93IBA 11/2013
1	AMPA Receptors (AMPA Receptor)IBA 11/2013
1	GYKI 52466IBA 11/2013
1	Aminobutyrates (Aminobutyric Acid)IBA 11/2013
1	bisperoxo(1,10- phenanthroline)oxovanadate(1- )IBA 07/2013
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 07/2013
1	Vanadates (Orthovanadate)IBA 07/2013
1	ifenprodilIBA 11/2011
1	protein kinase modulatorIBA 05/2011
1	Diazepam (Valium)FDA LinkGeneric 05/2011
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 05/2011
1	GABA-A Receptor AntagonistsIBA 05/2011
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2007
1	BerberineIBA 09/2007

Therapy/Procedure

3	Spinal Injections 07/2013 - 05/2011
2	Analgesia 05/2018 - 11/2017
1	Therapeutics 05/2021
1	Intraperitoneal Injections 05/2018